About Kymanox
Kymanox is a Healthcare company based in Arizona City (United States) founded in 2000, and was acquired by Kymanox in March 2023. Regulatory, training, and market access consulting services are offered. It operates on a Professional Services model. Kymanox offers products and services including Human Factors Engineering, Regulatory Strategy and Consulting, and Instructional Labeling and Training. Its focus areas include Medical Devices and Human Factors Engineering. Its legal entity is Kymanox Corporation. Its competitors include Indegene, IntegriChain and ClearView Healthcare Partners; 2 of its 3 listed competitors have raised funding.
Company details
Kymanox is involved in providing Human Factors Engineering services for medical devices and pharmaceuticals. Comprehensive solutions are offered across product development lifecycles, focusing on usability engineering, regulatory compliance, and risk management. Services are extended to various sectors including combination products, biotechnology, and diagnostics. Innovative approaches are integrated to enhance user experiences and improve healthcare outcomes. Support is also provided for instructional labeling, training, and regulatory strategy to ensure compliance with industry standards.
- Headquarters Arizona City, United States
- Stage Acquired
- SectorsHealthcare
- Phone•••• ••••
- Website agilisconsulting.com
- Social LinkedIn
- Acquired by Kymanox (Mar 2023)
- Legal Name Kymanox Corporation
Products & Services of Kymanox
Kymanox offers a comprehensive portfolio of products and services, including Human Factors Engineering, Regulatory Strategy and Consulting, and Instructional Labeling and Training.
Human Factors Engineering is provided for product usability.
Regulatory guidance is offered for compliance with standards.
Labeling and training are developed for user performance.
Investors in Kymanox
Kymanox has secured backing from 1 investor. Prominent investors backing the company include Kymanox.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Commercialization, validation, and consulting services for vital medicines are provided. | 2004 | kymanox.com | Morrisville, United States |
Investor details for Kymanox
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Kymanox
2 dated milestones of Kymanox across 23 years, from founding to its latest funding, stage changes and deals.
- Founded Kymanox is founded.
- Exit Acquired by Kymanox.
Competitors of Kymanox
Kymanox has 3 listed competitors in our database, 2 of them funded. They include Indegene, IntegriChain and ClearView Healthcare Partners.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| indegene.com | 1998 | Princeton, United States | $220M | 350 | Suite solutions are provided for payers and healthcare providers. | |
| integrichain.com | 2005 | Philadelphia, United States | $2M | 320 | Inventory, order and customer relationship management solution for life science suppliers. | |
| clearviewhcp.com | 2008 | Newton, United States | 381 | Strategic consulting services are provided to life sciences companies. |
Detailed competitors of Kymanox
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Kymanox (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Kymanox
Complete news archive for Kymanox
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kymanox
Kymanox was founded in 2000.
Kymanox is headquartered in Arizona City, United States. It is registered at Arizona City, Arizona, United States.
Kymanox is involved in providing Human Factors Engineering services for medical devices and pharmaceuticals. Comprehensive solutions are offered across product development lifecycles, focusing on usability engineering, regulatory compliance, and risk management. Services are extended to various sectors including combination products, biotechnology, and diagnostics. Innovative approaches are integrated to enhance user experiences and improve healthcare outcomes. Support is also provided for instructional labeling, training, and regulatory strategy to ensure compliance with industry standards.
Kymanox's top competitors include Indegene, IntegriChain and ClearView Healthcare Partners.
Kymanox offers Human Factors Engineering, Regulatory Strategy and Consulting, and Instructional Labeling and Training.
Kymanox has 1 investor. Key investors include Kymanox.
Kymanox operates through Kymanox Corporation.
Yes. Kymanox was acquired by Kymanox in March 2023.

